Jorie Versmissen

Jorie Versmissen is a Pharmacy Researcher at Erasmus MC, affiliated with the Department of Internal Medicine and the Erasmus School of Medicine. Her research is highly interdisciplinary, focusing on cardiovascular pharmacology, antihypertensive therapy, and clinical pharmacy, with significant contributions to understanding treatment adherence and pharmacotherapy in chronic diseases.

Her research interests center on antihypertensive drugs, resistant hypertension, cardiovascular risk assessment, and pharmacotherapy optimization. She actively investigates patient perceptions and barriers to treatment adherence in hypertension across Europe. Additionally, her work extends to oncology pharmacology, particularly the cardiovascular side effects of immune checkpoint inhibitors in melanoma patients, including thromboembolism and atherosclerosis progression.

The analysis of her recent publications reveals a strong trend towards clinical and translational research, often employing cohort studies, randomized controlled trials, and cross-sectional surveys. Her work bridges internal medicine, pharmacy, and public health, with a focus on improving patient outcomes through optimized drug therapy and error reduction in hospital settings.

She was awarded the ESH Pieter van Zwieten award in 2023 for her contributions to cardiovascular pharmacology, a prestigious recognition from the European Society of Hypertension.

• ESH Pieter van Zwieten award (2023)

Dr. Versmissen has supervised five research projects, indicating an active role in mentoring junior researchers and contributing to academic training. While specific grant details are not mentioned, her involvement in multi-center studies like the COvid MEdicaTion (COMET) Research Team suggests participation in large-scale collaborative research initiatives. She has also engaged in public outreach through media contributions, including a popular article on nutrition and hypertension featured on Nu.nl.

Her research collaborations span multiple departments at Erasmus MC, particularly between internal medicine, pharmacy, and oncology. She is part of interdisciplinary teams such as the COMET Research Team and collaborates with experts in cardiology, oncology, and clinical pharmacology. Her work is supported by institutional and possibly external funding, enabling high-impact publications in peer-reviewed journals.